The Thyroid Function Testing Market was valued at USD 1.68 billion in 2023 and is expected to reach USD 2.74 billion by 2032, growing at a CAGR of 5.58% from 2024-2032.
The Thyroid Function Testing Market report offers insights into thyroid disease prevalence and incidence rates between 2023 to 2032, noting trends in regional disease burden. The report discusses testing volume patterns and evaluating the growing need for TSH, T3, and T4 tests in major markets. The report further analyzes the adoption of automated and point-of-care thyrotropin tests, enhancing diagnostic access. Moreover, it explores healthcare spending on thyroid diagnosis, dividing costs into government, private, and out-of-pocket spending. Finally, it offers a detailed examination of regulatory approvals and standardization initiatives influencing the precision and reliability of thyroid function tests worldwide.
The U.S. dominated the North American Thyroid Function Testing Market because of its prevalence of thyroid diseases, at an estimated 20 million Americans. The nation is strongest in advanced diagnostic facilities, with extensive use of automated immunoassay platforms and point-of-care testing. Greater health care spending, over USD 3.5 trillion per annum, funds broad-based thyroid screening programs. Additionally, the availability of major market players such as Abbott, Roche, and Siemens Healthineers guarantees ongoing innovation and availability of thyroid function tests.
Drivers
Rising Prevalence of Thyroid Disorders is Driving Demand for Testing and accelerating the market growth.
The growing incidence of thyroid conditions worldwide, such as hypothyroidism, hyperthyroidism, and autoimmune thyroid disorders, is the primary force for the market for thyroid function tests. Based on the American Thyroid Association, one in every eight Americans will have a thyroid disorder in his or her lifetime. The burden of thyroid illness has been growing, which has increased the demand for TSH, T3, and T4 tests that are vital in early detection and treatment follow-up. In addition, growing Hashimoto's thyroiditis and Graves' disease incidence have resulted in higher test frequencies. New technologies, including Siemens Healthineers' ADVIA Centaur and IMMULITE 2000 thyroid function tests, are enhancing assay accuracy and efficiency. The growth of automated immunoassay analyzers and point-of-care testing further increases availability and facilitates market growth.
Technological Advancements in Diagnostic Assays Enhancing Accuracy and propelling the market growth.
Development of high-sensitivity immunoassays and molecular diagnostics has considerably improved the accuracy and dependability of thyroid function testing. Standard ELISA-based testing has increasingly given way to modern chemiluminescent immunoassays (CLIA), facilitating swift, accurate, and automated assessment. Manufacturers like Roche Diagnostics and Abbott Laboratories have commercialized automated thyroid function panels, lessening turnaround time while enhancing efficiency. Additionally, the introduction of biosensors and microfluidic-based point-of-care systems has increased testing accessibility in distant regions. Roche introduced the Elecsys TSH and Elecsys Free T3/T4 assays in 2023, which provide improved sensitivity to identify thyroid dysfunction at an early stage. As laboratories are moving toward AI-based diagnostic platforms, the market is shifting towards individualized and real-time tracking of thyroid conditions.
Restraint
High cost and limited accessibility of advanced thyroid function tests are restraining the market growth.
The prohibitive price of newer thyroid function testing technologies, especially chemiluminescent immunoassays (CLIA) and molecular diagnostic tests, is a major market growth hindrance. Although these technologies are highly sensitive and quick to produce results, they are costly to run on automated analyzers and need specialized laboratory facilities, hence not easily available in low- and middle-income countries (LMICs). In addition, reimbursement restrictions in healthcare in some areas limit access to frequent thyroid function testing, especially for diseases such as subclinical hypothyroidism that are not always reimbursed. The absence of point-of-care diagnostic solutions also restricts the availability of testing in rural and underserved communities. While organizations such as Siemens Healthineers and Roche Diagnostics are developing affordable thyroid testing options, being affordable continues to present a challenge, impacting early diagnosis and ongoing monitoring of thyroid conditions.
Opportunities
The increasing need for quick and convenient diagnostic solutions has presented a major opportunity for point-of-care thyroid function tests (POCT).
Conventional laboratory-based thyroid tests are expensive, require skilled personnel and special equipment, and take longer to process, hence less convenient for instant diagnosis and monitoring. POCT devices, including immunoassay-based rapid tests and portable analyzers, facilitate quicker results, enhancing early detection and disease management. Firms such as Boditech Med and Quidel Corporation are creating portable, user-friendly thyroid function testing kits, increasing availability in primary healthcare and rural facilities. Furthermore, the incorporation of smartphone-enabled diagnostics and AI-enabled analysis in the testing of thyroid function is bound to increase precision, speed, and real-time tracking, enhancing market potential through telemedicine and home-based tests.
Challenges
One of the significant challenges in the Thyroid Function Testing Market is that there is no standardization of various assay methods, which results in non-uniform test results.
The thyroid function is evaluated by a range of immunoassays, such as ELISA, radioimmunoassays, and chemiluminescent assays, each of which utilizes distinct calibration processes and sensitivity. Inter-laboratory variability of reference ranges may lead to inconsistency in diagnosing thyroid diseases, rendering it challenging for clinicians to depend on standardized results across testing platforms. Furthermore, confounding factors like biotin supplements, heterophile antibodies, and underlying disease may also compromise test accuracy, with the possibility of misdiagnosis. In response to this challenge, regulatory agencies like the FDA and the IFCC (International Federation of Clinical Chemistry and Laboratory Medicine) are endeavoring to harmonize thyroid assays, but achieving full standardization continues to be a problem for producers and clinicians.
Segmentation Analysis
By Test Type
The TSH (Thyroid-Stimulating Hormone) segment dominated the thyroid function testing market in 2023 with a 42.21% market share, because of its accuracy, affordability, and leading position in the diagnosis of thyroid disorders. TSH testing is the gold standard for the detection of hypothyroidism and hyperthyroidism because it can measure thyroid function accurately by assessing hormone levels based on the pituitary gland's signals. Worldwide medical guidelines, including those of the American Thyroid Association (ATA) and the Endocrine Society, prefer TSH testing as the initial diagnostic tool for thyroid disease. Moreover, the escalating incidence of thyroid diseases globally, increased use of point-of-care (POC) TSH testing, and heightened awareness of preventive health screening have driven the dominance of the segment. The prevalence of use of automated immunoassay analyzers in clinical laboratories and hospitals has further established TSH testing as the first choice for thyroid function assessment.
By End-Use
The Hospitals segment dominated the thyroid function testing market with a 38.45% market share in 2023 because of the large patient flow, presence of sophisticated diagnostic machines, and access to specialized healthcare providers. Hospitals are the main centers for diagnosing and treating thyroid diseases, providing complete testing panels, such as TSH, T3, T4, and antibody tests, under one roof. The hospital preference is also spurred by the amalgamation of laboratory services with internal medicine and endocrinology departments to provide proper diagnosis and instant clinical intervention. Hospitals also have the advantage of increased testing volume and reimbursement benefits, which are a major preference for patients, especially those who have complicated thyroid diseases. Increased usage of automated analyzers and point-of-care testing (POCT) in hospital environments has also cemented their supremacy, allowing for quicker and more accurate assessments of thyroid function.
Regional Analysis
North America dominated the thyroid function testing market with a 43.42% market share in 2023, owing to its well-developed healthcare infrastructure, strong awareness of thyroid diseases, and robust presence of market leaders. The region experiences a high incidence of thyroid conditions, with the American Thyroid Association (ATA) estimating that nearly 20 million Americans have thyroid diseases. Additionally, positive reimbursement policies, sophisticated diagnostic technology, and government programs promoting awareness of thyroid disease further drive market leadership. The increased use of automated immunoassay analyzers and relentless R&D initiatives by players such as Abbott, Siemens Healthineers, and Roche Diagnostics further fortify North America's dominance in thyroid function testing. The expanding utilization of point-of-care (POC) thyroid testing solutions and AI-powered diagnostic innovations also accelerates market expansion in the region.
The Asia Pacific region is experiencing the fastest growth in the thyroid function testing market with 6.14% CAGR throughout the forecast period, fueled by growing healthcare awareness, a growing number of thyroid disorder cases, and growing healthcare infrastructure. China, India, and Japan are seeing fast growth in the incidence of thyroid disease due mainly to lifestyle changes in diet, insufficient intake of iodine, and growing autoimmune diseases. The increasing investments in diagnostic laboratories, government programs for screening of thyroid disease, and enhanced access to diagnostic services are driving market growth. Moreover, the growth in telemedicine and home-based thyroid test solutions is increasing access to thyroid diagnostics. The arrival of international diagnostic players, the creation of affordable testing solutions, and the growing use of sophisticated immunoassays are the major drivers for the high growth prospects of the Asia Pacific thyroid function testing market.
Abbott Laboratories (Architect TSH Assay, Free T4 Assay)
Siemens Healthineers (ADVIA Centaur TSH, IMMULITE 2000 Free T4 Assay)
Roche Diagnostics (Elecsys TSH, Elecsys Free T3)
Beckman Coulter, Inc. (Access TSH, Access Free T4)
Bio-Rad Laboratories, Inc. (Lyphochek Immunoassay Plus, Liquichek Specialty Immunoassay Control)
DiaSorin S.p.A. (LIAISON TSH, LIAISON Free T4 Assay)
Ortho Clinical Diagnostics (VITROS TSH Assay, VITROS Free T3)
Thermo Fisher Scientific Inc. (ELISA Thyroid Panel, ImmunoCAP TSH Assay)
Randox Laboratories Ltd. (TSH Ultra Assay, Free T3 ELISA Test)
Euroimmun AG (EUROLINE Autoimmune Thyroid, ELISA Thyroglobulin Antibody)
Immunodiagnostic Systems Holdings PLC (IDS) (IDS-iSYS Free T4, IDS-iSYS TSH)
Boditech Med Inc. (Ichroma TSH, Ichroma Free T4)
Zivak Technologies (TSH ELISA Kit, Thyroid Function Panel)
Snibe Diagnostic (MAGLUMI TSH, MAGLUMI FT4)
DRG International, Inc. (DRG Free T3 ELISA, DRG TSH Ultra-Sensitive)
NovaTec Immundiagnostica GmbH (NovaLisa TSH, NovaLisa Free T4)
Seramun Diagnostica GmbH (Serazym TSH ELISA, Serastest Free T3)
Gold Standard Diagnostics (Thyroid Stimulating Hormone Rapid Test, ELISA Free T4)
MP Biomedicals (TSH ELISA Kit, Triiodothyronine (T3) Assay)
Quidel Corporation (Sofia Free T4 FIA, QuickVue TSH Test)
Suppliers (These suppliers commonly provide essential raw materials, including antibodies, reagents, assay kits, calibration standards, and quality control solutions required for manufacturing thyroid function testing products.) in the Thyroid Function Testing Market
Merck KGaA
Thermo Fisher Scientific Inc.
Bio-Rad Laboratories, Inc.
PerkinElmer, Inc.
Agilent Technologies, Inc.
Randox Laboratories Ltd.
Roche Custom Biotech
Abbott Diagnostics Suppliers Division
Siemens Healthineers Supply Chain
Sekisui Diagnostics
In September 2023, Beckman Coulter was granted FDA 510(k) clearance for its new Access Thyroglobulin Antibody II assay. This immunoassay is quantitative and measures the level of thyroglobulin antibody in plasma and serum and helps diagnose thyroid-related illnesses like Hashimoto's disease, nontoxic goiter, and Graves' disease. The assay is designed for use on Beckman Coulter's Access Immunoassay analyzers and improves diagnostic accuracy in thyroid function testing.
In August 2024, Siemens Healthineers launched the Atellica CI Analyzer in Mahajan Imaging & Labs in India. This cutting-edge diagnostic device can analyze more than 200 parameters for 20 disease states, such as thyroid function tests. Microvolume technology from the analyzer facilitates effective testing from small volumes of samples, favoring pediatric and critical care settings. The device also provides fast results with critical tests taken in 14 minutes, hence optimizing diagnostic productivity in thyroid function testing.
| Report Attributes | Details |
|---|---|
| Market Size in 2023 | US$ 1.68 billion |
| Market Size by 2032 | US$ 2.74 billion |
| CAGR | CAGR of 5.58% From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Test Type (TSH Test, T4 Test, T3 Test, Free T4 Test, Free T3 Test, Others) • By End-use (Clinics, Diagnostic Laboratories, Hospitals, Research Laboratories & Institutes) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia, Rest of Latin America) |
| Company Profiles | Abbott Laboratories, Siemens Healthineers, Roche Diagnostics, Beckman Coulter, Inc., Bio-Rad Laboratories, Inc., DiaSorin S.p.A., Ortho Clinical Diagnostics, Thermo Fisher Scientific Inc., Randox Laboratories Ltd., Euroimmun AG, Immunodiagnostic Systems Holdings PLC (IDS), Boditech Med Inc., Zivak Technologies, Snibe Diagnostic, DRG International, Inc., NovaTec Immundiagnostica GmbH, Seramun Diagnostica GmbH, Gold Standard Diagnostics, MP Biomedicals, Quidel Corporation, and other players. |
Ans: The Thyroid Function Testing Market is expected to grow at a CAGR of 5.58% from 2024-2032.
Ans: The Thyroid Function Testing Market was USD 1.68 billion in 2023 and is expected to reach USD 2.74 billion by 2032.
Ans: Technological Advancements in Diagnostic Assays are Enhancing Accuracy and propelling the market growth.
Ans: The “TSH Test” segment dominated the Thyroid Function Testing Market.
Ans: North America dominated the Thyroid Function Testing Market in 2023.
Table of Contents:
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.2 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
5. Statistical Insights and Trends Reporting
5.1 Incidence and Prevalence of Thyroid Disorders (2023-2032)
5.2 Testing Volume Trends by Region (2023-2032)
5.3 Adoption of Automated and Point-of-Care Testing (2023-2032)
5.4 Healthcare Expenditure on Thyroid Function Testing (2023), by Region
5.5 Regulatory Approvals and Standardization of Thyroid Function Tests (2023-2032)
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Product Benchmarking
6.3.1 Product specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and Supply Chain Strategies
6.4.3 Expansion plans and new product launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. Thyroid Function Testing Market Segmentation, By Test Type
7.1 Chapter Overview
7.2 TSH Test
7.2.1 TSH Test Market Trends Analysis (2020-2032)
7.2.2 TSH Test Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3 T4 Test
7.3.1 T4 Test Market Trends Analysis (2020-2032)
7.3.2 T4 Test Market Size Estimates and Forecasts to 2032 (USD Billion)
7.4 T3 Test
7.4.1 T3 Test Market Trends Analysis (2020-2032)
7.4.2 T3 Test Market Size Estimates and Forecasts to 2032 (USD Billion)
7.5 Free T4 Test
7.5.1 Free T4 Test Market Trends Analysis (2020-2032)
7.5.2 Free T4 Test Market Size Estimates and Forecasts to 2032 (USD Billion)
7.6 Free T3 Test
7.6.1 Free T3 Test Market Trends Analysis (2020-2032)
7.6.2 Free T3 Test Market Size Estimates and Forecasts to 2032 (USD Billion)
7.7 Others
7.7.1 Others Market Trends Analysis (2020-2032)
7.7.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
8. Thyroid Function Testing Market Segmentation, By End User
8.1 Chapter Overview
8.2 Clinics
8.2.1 Clinics Market Trends Analysis (2020-2032)
8.2.2 Clinics Market Size Estimates and Forecasts to 2032 (USD Billion)
8.3 Diagnostic Laboratories
8.3.1 Diagnostic Laboratories Market Trends Analysis (2020-2032)
8.3.2 Diagnostic Laboratories Market Size Estimates and Forecasts to 2032 (USD Billion)
8.4 Hospitals
8.4.1 Hospitals Market Trends Analysis (2020-2032)
8.4.2 Hospitals Market Size Estimates and Forecasts to 2032 (USD Billion)
8.5 Research Laboratories & Institutes
8.5.1 Research Laboratories & Institutes Market Trends Analysis (2020-2032)
8.5.2 Research Laboratories & Institutes Market Size Estimates and Forecasts to 2032 (USD Billion)
9. Regional Analysis
9.1 Chapter Overview
9.2 North America
9.2.1 Trends Analysis
9.2.2 North America Thyroid Function Testing Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.2.3 North America Thyroid Function Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
9.2.4 North America Thyroid Function Testing Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.2.5 USA
9.2.5.1 USA Thyroid Function Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
9.2.5.2 USA Thyroid Function Testing Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.2.6 Canada
9.2.6.1 Canada Thyroid Function Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
9.2.6.2 Canada Thyroid Function Testing Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.2.7 Mexico
9.2.7.1 Mexico Thyroid Function Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
9.2.7.2 Mexico Thyroid Function Testing Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.3 Europe
9.3.1 Eastern Europe
9.3.1.1 Trends Analysis
9.3.1.2 Eastern Europe Thyroid Function Testing Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.3.1.3 Eastern Europe Thyroid Function Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
9.3.1.4 Eastern Europe Thyroid Function Testing Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.3.1.5 Poland
9.3.1.5.1 Poland Thyroid Function Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
9.3.1.5.2 Poland Thyroid Function Testing Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.3.1.6 Romania
9.3.1.6.1 Romania Thyroid Function Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
9.3.1.6.2 Romania Thyroid Function Testing Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.3.1.7 Hungary
9.3.1.7.1 Hungary Thyroid Function Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
9.3.1.7.2 Hungary Thyroid Function Testing Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.3.1.8 Turkey
9.3.1.8.1 Turkey Thyroid Function Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
9.3.1.8.2 Turkey Thyroid Function Testing Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.3.1.9 Rest of Eastern Europe
9.3.1.9.1 Rest of Eastern Europe Thyroid Function Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
9.3.1.9.2 Rest of Eastern Europe Thyroid Function Testing Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.3.2 Western Europe
9.3.2.1 Trends Analysis
9.3.2.2 Western Europe Thyroid Function Testing Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.3.2.3 Western Europe Thyroid Function Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
9.3.2.4 Western Europe Thyroid Function Testing Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.3.2.5 Germany
9.3.2.5.1 Germany Thyroid Function Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
9.3.2.5.2 Germany Thyroid Function Testing Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.3.2.6 France
9.3.2.6.1 France Thyroid Function Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
9.3.2.6.2 France Thyroid Function Testing Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.3.2.7 UK
9.3.2.7.1 UK Thyroid Function Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
9.3.2.7.2 UK Thyroid Function Testing Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.3.2.8 Italy
9.3.2.8.1 Italy Thyroid Function Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
9.3.2.8.2 Italy Thyroid Function Testing Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.3.2.9 Spain
9.3.2.9.1 Spain Thyroid Function Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
9.3.2.9.2 Spain Thyroid Function Testing Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.3.2.10 Netherlands
9.3.2.10.1 Netherlands Thyroid Function Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
9.3.2.10.2 Netherlands Thyroid Function Testing Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.3.2.11 Switzerland
9.3.2.11.1 Switzerland Thyroid Function Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
9.3.2.11.2 Switzerland Thyroid Function Testing Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.3.2.12 Austria
9.3.2.12.1 Austria Healthcare Predictive Analytic Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
9.3.2.12.2 Austria Thyroid Function Testing Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.3.2.13 Rest of Western Europe
9.3.2.13.1 Rest of Western Europe Thyroid Function Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
9.3.2.13.2 Rest of Western Europe Thyroid Function Testing Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.4 Asia Pacific
9.4.1 Trends Analysis
9.4.2 Asia Pacific Thyroid Function Testing Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.4.3 Asia Pacific Thyroid Function Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
9.4.4 Asia Pacific Thyroid Function Testing Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.4.5 China
9.4.5.1 China Thyroid Function Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
9.4.5.2 China Thyroid Function Testing Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.4.6 India
9.4.5.1 India Thyroid Function Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
9.4.5.2 India Thyroid Function Testing Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.4.5 Japan
9.4.5.1 Japan Thyroid Function Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
9.4.5.2 Japan Thyroid Function Testing Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.4.6 South Korea
9.4.6.1 South Korea Thyroid Function Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
9.4.6.2 South Korea Thyroid Function Testing Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.4.7 Vietnam
9.4.7.1 Vietnam Thyroid Function Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
9.2.7.2 Vietnam Healthcare Predictive Analytic Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.4.8 Singapore
9.4.8.1 Singapore Thyroid Function Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
9.4.8.2 Singapore Thyroid Function Testing Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.4.9 Australia
9.4.9.1 Australia Thyroid Function Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
9.4.9.2 Australia Thyroid Function Testing Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.4.10 Rest of Asia Pacific
9.4.10.1 Rest of Asia Pacific Thyroid Function Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
9.4.10.2 Rest of Asia Pacific Thyroid Function Testing Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.5 Middle East and Africa
9.5.1 Middle East
9.5.1.1 Trends Analysis
9.5.1.2 Middle East Thyroid Function Testing Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.5.1.3 Middle East Thyroid Function Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
9.5.1.4 Middle East Thyroid Function Testing Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.5.1.5 UAE
9.5.1.5.1 UAE Thyroid Function Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
9.5.1.5.2 UAE Thyroid Function Testing Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.5.1.6 Egypt
9.5.1.6.1 Egypt Thyroid Function Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
9.5.1.6.2 Egypt Thyroid Function Testing Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.5.1.7 Saudi Arabia
9.5.1.7.1 Saudi Arabia Thyroid Function Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
9.5.1.7.2 Saudi Arabia Thyroid Function Testing Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.5.1.8 Qatar
9.5.1.8.1 Qatar Thyroid Function Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
9.5.1.8.2 Qatar Thyroid Function Testing Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.5.1.9 Rest of Middle East
9.5.1.9.1 Rest of Middle East Thyroid Function Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
9.5.1.9.2 Rest of Middle East Thyroid Function Testing Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.5.2 Africa
9.5.2.1 Trends Analysis
9.5.2.2 Africa Thyroid Function Testing Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.5.2.3 Africa Thyroid Function Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
9.5.2.4 Africa Thyroid Function Testing Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.5.2.5 South Africa
9.5.2.5.1 South Africa Thyroid Function Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
9.5.2.5.2 South Africa Thyroid Function Testing Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.5.2.6 Nigeria
9.5.2.6.1 Nigeria Thyroid Function Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
9.5.2.6.2 Nigeria Thyroid Function Testing Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.5.2.7 Rest of Africa
9.5.2.7.1 Rest of Africa Thyroid Function Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
9.5.2.7.2 Rest of Africa Thyroid Function Testing Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.6 Latin America
9.6.1 Trends Analysis
9.6.2 Latin America Thyroid Function Testing Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.6.3 Latin America Thyroid Function Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
9.6.4 Latin America Thyroid Function Testing Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.6.5 Brazil
9.6.5.1 Brazil Thyroid Function Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
9.6.5.2 Brazil Thyroid Function Testing Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.6.6 Argentina
9.6.6.1 Argentina Thyroid Function Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
9.6.6.2 Argentina Thyroid Function Testing Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.6.7 Colombia
9.6.7.1 Colombia Thyroid Function Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
9.6.7.2 Colombia Thyroid Function Testing Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.6.8 Rest of Latin America
9.6.8.1 Rest of Latin America Thyroid Function Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
9.6.8.2 Rest of Latin America Thyroid Function Testing Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10. Company Profiles
10.1 Abbott Laboratories
10.1.1 Company Overview
10.1.2 Financial
10.1.3 Products/ Services Offered
110.1.4 SWOT Analysis
10.2 Siemens Healthineers
10.2.1 Company Overview
10.2.2 Financial
10.2.3 Products/ Services Offered
10.2.4 SWOT Analysis
10.3 Roche Diagnostics
10.3.1 Company Overview
10.3.2 Financial
10.3.3 Products/ Services Offered
10.3.4 SWOT Analysis
10.4 Beckman Coulter, Inc.
10.4.1 Company Overview
10.4.2 Financial
10.4.3 Products/ Services Offered
10.4.4 SWOT Analysis
10.5 Bio-Rad Laboratories, Inc.
10.5.1 Company Overview
10.5.2 Financial
10.5.3 Products/ Services Offered
10.5.4 SWOT Analysis
10.6 DiaSorin S.p.A.
10.6.1 Company Overview
10.6.2 Financial
10.6.3 Products/ Services Offered
10.6.4 SWOT Analysis
10.7 Ortho Clinical Diagnostics
10.7.1 Company Overview
10.7.2 Financial
10.7.3 Products/ Services Offered
10.7.4 SWOT Analysis
10.8 Thermo Fisher Scientific Inc.
10.8.1 Company Overview
10.8.2 Financial
10.8.3 Products/ Services Offered
10.8.4 SWOT Analysis
10.9 Randox Laboratories Ltd.
10.9.1 Company Overview
10.9.2 Financial
10.9.3 Products/ Services Offered
10.9.4 SWOT Analysis
10.10 Euroimmun AG
10.9.1 Company Overview
10.9.2 Financial
10.9.3 Products/ Services Offered
10.9.4 SWOT Analysis
11. Use Cases and Best Practices
12. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
Thyroid Function Testing Market
Key Segments:
By Test Type
TSH Test
T4 Test
T3 Test
Free T4 Test
Free T3 Test
Others
By End-Use
Clinics
Diagnostic Laboratories
Hospitals
Research Laboratories & Institutes
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
Detailed Volume Analysis
Criss-Cross segment analysis (e.g. Product X Application)
Competitive Product Benchmarking
Geographic Analysis
Additional countries in any of the regions
Customized Data Representation
Detailed analysis and profiling of additional market players
The Allergic Conjunctivitis Market size was valued at USD 3.03 billion in 2023 and is expected to reach USD 4.90 billion by 2032 with an emerging CAGR of 5.7% Over the Forecast Period of 2024-2032.
Preterm Birth and PROM Testing Market was valued at USD 1.5 billion in 2023 and is expected to reach USD 2.93 billion by 2032, growing at a CAGR of 7.7% over the forecast period 2024-2032.
The Accountable Care Solutions Market Size was valued at USD 23.12 Billion in 2023 and is expected to reach USD 61.45 Billion by 2032 and grow at a CAGR of 11.50% over the forecast period 2024-2032
The Antibody Drug Conjugates [ADC] Market was valued at USD 10.28 billion in 2023 and is expected to reach USD 29.10 billion by 2032, growing at a CAGR of 12.29% from 2024-2032.
The Demineralized Bone Matrix (DBM) Market Size was valued at USD 1.29 billion in 2023 and is projected to reach USD 2.18 billion by 2032 with a growing CAGR of 5.98% Over the Forecast Period of 2024-2032.
The Cell Therapy Market was valued at USD 4.65 Billion in 2023 and is expected to reach USD 28.98 billion by 2032 and grow at a CAGR of 22.55% over the forecast period 2024-2032.
Hi! Click one of our member below to chat on Phone
© 2025 All Rights Reserved by SNS Insider Pvt Ltd
